Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Novel GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma Exploratory Clinical Studies

NCT05344664 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05344664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05344664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Novel GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma Exploratory Clinical Studies
Lead sponsor
Peking University
Phase
Phase 1
Overall status
Unknown status
Start date
April 14, 2022
Completion date
February 1, 2025
Enrollment
12 (estimated)
Sites
Not reported